Show Summary Details
Page of

Radioimmunotherapy for lymphoma 

Radioimmunotherapy for lymphoma
Radioimmunotherapy for lymphoma

Tim Illidge

and Yong Du

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 12 August 2020

Chapter 7 covers radioimmunotherapy for lymphoma, including non-Hodgkin lymphoma (NHL), clinical indications, typical doses, precautions and side effects, clinical efficacy, and alternative treatments.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.